728 related articles for article (PubMed ID: 26879848)
1. Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.
Ensor J; Riley RD; Jowett S; Monahan M; Snell KIe; Bayliss S; Moore D; Fitzmaurice D;
Health Technol Assess; 2016 Feb; 20(12):i-xxxiii, 1-190. PubMed ID: 26879848
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE.
Ensor J; Riley RD; Moore D; Snell KI; Bayliss S; Fitzmaurice D
BMJ Open; 2016 May; 6(5):e011190. PubMed ID: 27154483
[TBL] [Abstract][Full Text] [Related]
3. Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation.
Pandor A; Horner D; Davis S; Goodacre S; Stevens JW; Clowes M; Hunt BJ; Nokes T; Keenan J; de Wit K
Health Technol Assess; 2019 Dec; 23(63):1-190. PubMed ID: 31851608
[TBL] [Abstract][Full Text] [Related]
4. Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE.
Ensor J; Riley RD; Moore D; Bayliss S; Jowett S; Fitzmaurice DA
Syst Rev; 2013 Oct; 2():91. PubMed ID: 24089702
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of strategies for restarting anticoagulation therapy after a first event of unprovoked venous thromboembolism.
Monahan M; Ensor J; Moore D; Fitzmaurice D; Jowett S
J Thromb Haemost; 2017 Aug; 15(8):1591-1600. PubMed ID: 28520199
[TBL] [Abstract][Full Text] [Related]
6. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism.
Verhovsek M; Douketis JD; Yi Q; Shrivastava S; Tait RC; Baglin T; Poli D; Lim W
Ann Intern Med; 2008 Oct; 149(7):481-90, W94. PubMed ID: 18838728
[TBL] [Abstract][Full Text] [Related]
7. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
[TBL] [Abstract][Full Text] [Related]
8. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
9. Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research.
Davis S; Pandor A; Sampson FC; Hamilton J; Nelson-Piercy C; Hunt BJ; Daru J; Goodacre S; Carser R; Rooney G; Clowes M
Health Technol Assess; 2024 Mar; 28(9):1-176. PubMed ID: 38476084
[TBL] [Abstract][Full Text] [Related]
10. Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? A systematic review, network meta-analysis, and decision analysis.
Djulbegovic M; Lee AI; Chen K
J Eval Clin Pract; 2020 Feb; 26(1):7-17. PubMed ID: 31190408
[TBL] [Abstract][Full Text] [Related]
11. Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data.
Marcucci M; Iorio A; Douketis JD; Eichinger S; Tosetto A; Baglin T; Cushman M; Palareti G; Poli D; Tait RC; Kyrle PA
J Thromb Haemost; 2015 May; 13(5):775-81. PubMed ID: 25660555
[TBL] [Abstract][Full Text] [Related]
12. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
13. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).
Tosetto A; Iorio A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Douketis J
J Thromb Haemost; 2012 Jun; 10(6):1019-25. PubMed ID: 22489957
[TBL] [Abstract][Full Text] [Related]
14. Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal.
de Winter MA; van Es N; Büller HR; Visseren FLJ; Nijkeuter M
Thromb Res; 2021 Mar; 199():85-96. PubMed ID: 33485094
[TBL] [Abstract][Full Text] [Related]
15. External validation of the DASH prediction rule: a retrospective cohort study.
Tosetto A; Testa S; Martinelli I; Poli D; Cosmi B; Lodigiani C; Ageno W; De Stefano V; Falanga A; Nichele I; Paoletti O; Bucciarelli P; Antonucci E; Legnani C; Banfi E; Dentali F; Bartolomei F; Barcella L; Palareti G
J Thromb Haemost; 2017 Oct; 15(10):1963-1970. PubMed ID: 28762665
[TBL] [Abstract][Full Text] [Related]
16. Prognostic models for identifying risk of poor outcome in people with acute ankle sprains: the SPRAINED development and external validation study.
Keene DJ; Schlüssel MM; Thompson J; Hagan DA; Williams MA; Byrne C; Goodacre S; Cooke M; Gwilym S; Hormbrey P; Bostock J; Haywood K; Wilson D; Collins GS; Lamb SE
Health Technol Assess; 2018 Nov; 22(64):1-112. PubMed ID: 30474592
[TBL] [Abstract][Full Text] [Related]
17. Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).
Timp JF; Braekkan SK; Lijfering WM; van Hylckama Vlieg A; Hansen JB; Rosendaal FR; le Cessie S; Cannegieter SC
PLoS Med; 2019 Oct; 16(10):e1002883. PubMed ID: 31603898
[TBL] [Abstract][Full Text] [Related]
18. Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study.
Xu Y; Khan F; Kovacs MJ; Sabri E; Carrier M; Righini M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Crowther MA; White RH; Rodger M; Le Gal G
Thromb Res; 2023 Nov; 231():32-38. PubMed ID: 37801772
[TBL] [Abstract][Full Text] [Related]
19. Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores.
van Es N; Wells PS; Carrier M
Thromb Res; 2017 Apr; 152():52-60. PubMed ID: 28237891
[TBL] [Abstract][Full Text] [Related]
20. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
